“The results from these evaluations confirmed that the Amyris No Compromise renewable diesel production process performs well across different sugar sources. Ceres’ sweet sorghum hybrids produced sugars that yielded comparable levels of farnesene as sugarcane and other sugar sources Amyris has utilized,” said Todd Pray, Amyris director of product management. “Sweet sorghum can provide timely feedstock flexibility with environmental benefits. We look forward to utilizing Ceres’ sweet sorghum in our commercial-scale production facilities,” Pray concluded.
As a dedicated energy crop, sweet sorghum has a number of advantages. It is fast-growing and can efficiently produce both large amounts of fermentable sugars and biomass. The plants require substantially less fertilizer than sugarcane, and can be grown in drier areas since they utilize water more efficiently.
Ceres first commercialized its improved hybrids in Brazil this season. This spring, Ceres also introduced its first two hybrids to supply larger-scale evaluations in the United States. Ceres anticipates Florida and the Gulf Coast as well as California’s Imperial Valley, Arizona and Hawaii could be markets for sweet sorghum production.
ABOUT CERESCeres, Inc. is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. Ceres combines advanced plant breeding and biotechnology to develop products that can address the limitations of first-generation bioenergy feedstocks, increase biomass productivity, reduce crop inputs and improve cultivation on marginal land. Its development activities include sweet sorghum, high-biomass sorghum, switchgrass and miscanthus. Ceres markets its products under its Blade brand. CERES FORWARD-LOOKING STATEMENTS This press release may contain forward-looking statements. All statements, other than statements of historical facts, including statements regarding our efforts to develop and commercialize our products, our short-term and long-term business strategies, market and industry expectations, future operating metrics, product yields and future results of operations and financial position, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond our control. Factors that could materially affect actual results can be found in Ceres’ filings with the U.S. Securities and Exchange Commission. Ceres undertakes no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing Ceres’ views as of any date subsequent to the date of this press release. Amyris, No Compromise and Biofene are trademarks or registered trademarks of Amyris, Inc.